News
Palliative radiotherapy successfully reduces end-stage liver cancer pain
Small study shows low-dose radiotherapy improves both pain and survival in hepatocellular carcinoma.
News
Topical CBD oil study suggests benefits for pain, healing in systemic sclerosis digital ulcers
A small study of the cannabis component is a ‘good first step,’ rheumatologist says.
News
VEXAS syndrome: More common, variable, and severe than expected
A large U.S. analysis found that this newly discovered genetic disease has a estimated prevalence of 1 in 4,269 in men older than 50.
News
Mpox: Dermatology registry data pinpoints unique signs
Skin lesions are more likely to precede systemic illness, and overall lesion numbers are lower.
News
Off their pricey CML meds, many thrive
For CML patients in remission, specialists suggest trying drug omission – which often yields good outcomes and a reprieve from side effects.
News
Surgeon’s license suspension spotlights hazards, ethics of live-streaming surgeries
The doctor was accused of engaging in dialogue to respond to viewers’ online questions while a surgical procedure remained actively ongoing, among...
News
COVID update: ASH experts discuss thrombosis, immunity
Presidential symposium plumbs the mysteries of an “extraordinarily stealthy” virus, considers postvaccine blood clots.
News
AAP offers new guidance on child exploitation and sex trafficking
By virtue of their young age and stage of mental and emotional development, children and adolescents are vulnerable to manipulation and...
Article
Immunotherapy drug boosts survival in newly diagnosed ALL
First-line treatment with expensive medication should become standard, researcher says.
News
Antipsychotic shows benefit for Alzheimer’s agitation
Currently, there’s no Food and Drug Administration–approved treatment for agitation in AD.
News
Study: Formula-fed extreme preemies need more iron
It’s time to rethink the guidelines on nutritional supplementation for the most premature babies, researchers said.
News
ITP: Biologic beat placebo, but few patients improved
Exorbitant efgartigimod meets primary endpoint in only 21.8% of patients with chronic disease.
News
MCL: Ibrutinib could become the ‘new standard’
New research showed ibrutinib outperformed HSCT for treating younger patients with mantle cell lymphoma.
News
SSRI tied to improved cognition in comorbid depression, dementia
Evidence suggests the drug’s receptor targets “have the potential to modulate neurotransmitter systems that are essential for regulation of...
News
Melanoma mortality rates fell in 2010s as new therapies took hold
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.